التفاصيل البيبلوغرافية
| العنوان: |
Late Vasopressor Administration in Patients in the ICU: A Retrospective Cohort Study. |
| المؤلفون: |
Viglianti, Elizabeth M.1 (AUTHOR) eviglian@med.umich.edu, Bagshaw, Sean M.2 (AUTHOR), Bellomo, Rinaldo3,4 (AUTHOR), McPeake, Joanne5,6 (AUTHOR), Molling, Daniel J.7 (AUTHOR), Wang, Xiao Qing1 (AUTHOR), Seelye, Sarah7 (AUTHOR), Iwashyna, Theodore J.1,7,8 (AUTHOR) |
| المصدر: |
CHEST. Aug2020, Vol. 158 Issue 2, p571-578. 8p. |
| مصطلحات موضوعية: |
*COHORT analysis, *COMORBIDITY, *RETROSPECTIVE studies, *VASOCONSTRICTORS, *RESEARCH, *RESEARCH methodology, *MEDICAL cooperation, *EVALUATION research, *HOSPITAL mortality, *DRUG administration, *COMPARATIVE studies, *CRITICAL care medicine, *HOSPITAL care |
| مستخلص: |
Background: Little is known about the prevalence, predictors, and outcomes of late vasopressor administration which evolves after admission to the ICU.Research Question: What is the epidemiology of late vasopressor administration in the ICU?Study Design and Methods: We retrospectively studied a cohort of veterans admitted to the Veterans Administration ICUs for ≥ 4 days from 2014 to 2017. The timing of vasopressor administration was categorized as early (only within the initial 3 days), late (on day 4 or later and none on day 3), and continuous (within the initial 2 days through at least day 4). Regressions were performed to identify patient factors associated with late vasopressor administration and the timing of vasopressor administration with posthospitalization discharge mortality.Results: Among the 62,206 hospitalizations with at least 4 ICU days, late vasopressor administration occurred in 5.5% (3,429 of 62,206). Patients with more comorbidities (adjusted OR [aOR], 1.02 per van Walraven point; 95% CI, 1.02-1.03) and worse severity of illness on admission (aOR, 1.01 per percentage point risk of death; 95% CI, 1.01-1.02) were more likely to receive late vasopressor therapy. Nearly 50% of patients started a new antibiotic within 24 h of receiving late vasopressor therapy. One-year mortality after survival to discharge was higher for patients with continuous (adjusted hazard ratio [aHR], 1.48; 95% CI, 1.33-1.65) and late vasopressor administration (aHR, 1.26; 95% CI, 1.15-1.38) compared with only early vasopressor administration.Interpretation: Late vasopressor administration was modestly associated with comorbidities and admission illness severity. One-year mortality was higher among those who received late vasopressor administration compared with only early vasopressor administration. Research to understand optimization of late vasopressor therapy administration may improve long-term mortality. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
